Clinical Trials Directory

Trials / Completed

CompletedNCT05815056

Comparaison Between Digital and Drug Induced Sedation in Veinous Access Device Implantation

Comparaison Between Virtual Reality Hypnosis and Drug Induced Sedation in Veinous Access Device Implantation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Centre Hospitalier Regional de Huy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to compare in patients who need an implantation of a veinous access device the sedation with anesthesiologic drugs and with hypnosis using virtual reality material. The main question it aims to answer is: • is hypnosis using virtual reality as safe and powerfull than usual anesthesiologic drugs. Participants will complete a preoperative and postoperative questionnaire. They will be contacted by phone pre and postoperatively. If there is a comparison group: Researchers will compare drug induced sedation and hypnosis induced by virtual reality to see if they are similar in efficacy and sides effects.

Detailed description

This study has two arms. All patients has the same preparation to surgery. They had lorazepam 2.5 mg 30 minutes before the surgery. In operative theater, they are randomly chosen between anesthetic protocol (sufentanyl 5mg intravenous) or digital sedation (Sedakit(R) ) with hypnosis induced by virtual reality. Patients complete an anxiety test (hamilton scale) 2 days before the surgery and 2 days after the surgery. They are called by an external psychiatrist 1 day before the surgery and 3 days after to evaluate the anxiety link to the procedure.

Conditions

Interventions

TypeNameDescription
DEVICESedakit (R) using hypnosis induced by the virtual reality devicewe use the virtual reality device and no medication during the surgery
DRUGdrug interventionusing sufentanyl 5mg intravenously during the surgery

Timeline

Start date
2022-03-01
Primary completion
2022-08-22
Completion
2022-08-25
First posted
2023-04-18
Last updated
2023-04-18

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05815056. Inclusion in this directory is not an endorsement.